ReCode Therapeutics to Participate in Upcoming August Investor Conferences | Financial Buzz

ReCode Therapeutics to Participate in Upcoming August Investor Conferences

ReCode Therapeutics (the “Company”), a biopharmaceutical company pioneering disease-modifying genetic medicines using its proprietary LNP delivery platform, today announced that Company leadership will host 1×1 meetings at two upcoming virtual investor conferences in August:

  • Canaccord Genuity 41st Annual Growth Conference

    August 10 – 12, 2021
  • Wedbush PacGrow Healthcare Conference

    August 10 – 11, 2021

About ReCode Therapeutics

ReCode Therapeutics is an integrated genetic medicines company developing disease-modifying therapeutics using powerful LNP delivery technology to target organs and tissues beyond the liver. The Company’s pipeline includes lead programs for patients with life-limiting genetic respiratory diseases, including cystic fibrosis and primary ciliary dyskinesia. The Company is leveraging its proprietary LNP platform and nucleic acid technologies and utilizing systemic and direct delivery for mRNA-mediated replacement and gene editing/correction in target cells, including stem cells. For more information, visit and follow us on Twitter @ReCodeTx and LinkedIn.


Media Contact:

Will Zasadny

Canale Communications, Inc.

(619) 961-8848

Investor Contact:

Sarah McCabe

Stern Investor Relations

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!